Drag a card by its title · ⚙ to size, swap or remove

The company

Oric Pharmaceuticals, Inc.

ORIC · Nasdaq

Health CareBiotechnologyLeading

ORIC stood above a rising 150-day average in 26 of the last 52 weekly readings, including each of the last 12 weeks. It is 12.6% above that average now. Biotechnology: 15% of its 561 stocks in an uptrend (−17 points in four weeks); Health Care: 25% (−11 points in four weeks).

SEC filings

Statistics

Rotation: Leading
Weeks in an uptrend: 12 in a row
Industry in uptrend: 15% -17 in 4 wk
Insider buys, 12 months: $0
Insider sales, 12 months: $5.0M
Officials’ trades on record: 0
Institutions holding: 176 (+2)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 26 of 52 weeks.

17 Apr – 16 Oct

Biotechnology: Few of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months0

Sale orders, 12 months11

Buyers · sellers0 · 4

Who	Did	Shares	Traded
Richard A. HeymanDirector	sold	3,500at $12.91	1 Oct 2026filed 2 Oct 2026
Richard A. HeymanDirector	sold	3,200at $12.91	1 Oct 2026filed 2 Oct 2026
Dominic PiscitelliChief Financial Officer	sold	13,400at $13.53	28 Sep 2026filed 29 Sep 2026
Dominic PiscitelliChief Financial Officer	sold	100at $13.50	24 Sep 2026filed 25 Sep 2026
Dominic PiscitelliChief Financial Officer	sold	500at $13.51	24 Sep 2026filed 25 Sep 2026
Dominic PiscitelliChief Financial Officer	sold	77,000at $13.69	26 Aug 2026filed 28 Aug 2026
Richard A. HeymanDirector	sold	7,000at $12.02	24 Jul 2026filed 28 Jul 2026
Richard A. HeymanDirector	sold	6,100at $12.02	24 Jul 2026filed 28 Jul 2026
Richard A. HeymanDirector	sold	300at $12.00	6 Jul 2026filed 8 Jul 2026
Dominic PiscitelliChief Financial Officer	sold	52,000at $13.51	24 Feb 2026filed 26 Feb 2026
Richard A. HeymanDirector	sold	3,500at $12.00	16 Jan 2026filed 20 Jan 2026
Richard A. HeymanDirector	sold	3,200at $12.00	16 Jan 2026filed 20 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders176+2 on the quarter

New · exited31 · 29

Reported value$1.3B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

Manager	Shares	Change
Nextech Invest Ltd.unchanged · filed 14 Aug 2026	7,162,637$77.6M	00.0%
BlackRock, Inc.added · filed 7 Aug 2026	6,823,973$73.9M	+839,421+14.0%
EcoR1 Capital, LLCunchanged · filed 14 Aug 2026	6,728,116$72.9M	00.0%
VIKING GLOBAL INVESTORS LPreduced · filed 14 Aug 2026	5,126,762$55.5M	-697,771−12.0%
STATE STREET CORPadded · filed 7 Aug 2026	4,894,000$53.0M	+1,191,804+32.2%
SR One Capital Management, LPadded · filed 12 Aug 2026	4,615,384$50.0M	+100,455+2.2%
Venrock Adviser, LLCunchanged · filed 14 Aug 2026	4,319,765$46.8M	00.0%
NEA Management Company, LLCunchanged · filed 14 Aug 2026	4,118,621$44.6M	00.0%
VANGUARD CAPITAL MANAGEMENT LLCadded · filed 13 Aug 2026	3,951,169$42.8M	+264,162+7.2%
AIHC Capital Management Ltdadded · filed 13 Aug 2026	3,828,460$41.5M	+1,368,909+55.7%